|
|
||||
|
Barriers on the Road to New Antibiotics
Regulatory obstacles and lack of investment are in the way of innovation
Email: Naomi Balaban - naomi.balaban@tufts.edu; Giorgio Dell'Acqua - giorgio_dellacqua@hotmail.com The Scientist 2005, 19(5):42
|
||||
|
|
||||
|
Antibiotics have been around since the introduction of penicillin in the 1940s, but the fight against bacterial infections is far from over. The emergence of resistant strains or "superbugs" has made bacterial infections increasingly difficult to treat with available antibiotics. Staphylococcus aureus is one of the most challenging; it is responsible for half of hospital-associated infections and claims the lives of about 100,000 patients each year in the United States alone.[1]
|
|
|||||||||
|
|||||||||
|